Cargando…

Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis

Vitamin D deficiency is associated with poor mental health and dysmetabolism. Several metabolic abnormalities are associated with psychotic diseases, which can be compounded by atypical antipsychotics that induce weight gain and insulin resistance. These side-effects may be affected by vitamin D lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abolghasemi, Armita, Manca, Claudia, Iannotti, Fabio A., Shen, Melissa, Leblanc, Nadine, Lacroix, Sébastien, Martin, Cyril, Flamand, Nicolas, Di Marzo, Vincenzo, Silvestri, Cristoforo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620071/ https://www.ncbi.nlm.nih.gov/pubmed/34830242 http://dx.doi.org/10.3390/ijms222212361

Ejemplares similares

Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice
por: Lacroix, Sébastien, et al.
Publicado: (2019)

The Gut Microbiome–Endocannabinoidome Axis: A New Way of Controlling Metabolism, Inflammation, and Behavior
por: Silvestri, Cristoforo, et al.
Publicado: (2023)

Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed
por: Ben Necib, Rim, et al.
Publicado: (2022)

Oral Capsaicinoid Administration Alters the Plasma Endocannabinoidome and Fecal Microbiota of Reproductive-Aged Women Living with Overweight and Obesity
por: Manca, Claudia, et al.
Publicado: (2021)

Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome
por: Shen, Mélissa, et al.
Publicado: (2021)

Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice
por: Venneri, Tommaso, et al.
Publicado: (2023)

Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
por: Di Marzo, Vincenzo, et al.
Publicado: (2019)

Dietary food patterns as determinants of the gut microbiome–endocannabinoidome axis in humans
por: Castonguay-Paradis, Sophie, et al.
Publicado: (2023)

Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota
por: Dione, Niokhor, et al.
Publicado: (2020)

Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat
por: Castonguay-Paradis, Sophie, et al.
Publicado: (2020)

Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity
por: Manca, Claudia, et al.
Publicado: (2021)

Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists
por: Depommier, Clara, et al.
Publicado: (2021)

The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders 
por: Di Marzo, Vincenzo
Publicado: (2020)

Impact of selenium on the intestinal microbiome-eCBome axis in the context of diet-related metabolic health in mice
por: Guevara Agudelo, Fredy Alexander, et al.
Publicado: (2022)

Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint †
por: Schiano Moriello, Aniello, et al.
Publicado: (2022)

The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity
por: Lauritano, Anna, et al.
Publicado: (2022)

Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study
por: Forteza, Fabiola, et al.
Publicado: (2022)

Targeting the Endocannabinoidome in Pancreatic Cancer
por: Falasca, Valerio, et al.
Publicado: (2022)

Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
por: Ishiguro, Hiroki
Publicado: (2023)

Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models
por: Depommier, Clara, et al.
Publicado: (2021)

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
por: Piscitelli, Fabiana, et al.
Publicado: (2011)

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
por: Kalkan, Hilal, et al.
Publicado: (2023)

Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome
por: Forteza, Fabiola, et al.
Publicado: (2021)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
por: Suriano, Francesco, et al.
Publicado: (2023)

The gut microbiome influences the bioavailability of olanzapine in rats
por: Cussotto, Sofia, et al.
Publicado: (2021)

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine
por: Santarelli, Danielle M., et al.
Publicado: (2013)

Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment
por: Grywińska, Weronika B., et al.
Publicado: (2023)

Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms
por: Wences Chirino, Tiffany, et al.
Publicado: (2023)

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013)

The Role of the Microbiome in Asthma: The Gut–Lung Axis
por: Frati, Franco, et al.
Publicado: (2018)

Obesity: The Fat Tissue Disease Version of Cancer
por: Boubertakh, Besma, et al.
Publicado: (2022)

Olanzapine/risperidone: Sedation, increased cholesterol levels and extrapyramidal side-effects in the form of akathisia: 3 case reports
Publicado: (2021)

Hyperbaric oxygen exposure alleviate metabolic side-effects of olanzapine treatment and is associated with Langerhans islet proliferation in rats
por: AlQudah, Mohammad, et al.
Publicado: (2022)

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
por: Morgan, Andrew P., et al.
Publicado: (2014)

Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
por: Silvestri, Cristoforo, et al.
Publicado: (2020)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients
por: Czekalla, Jörg, et al.
Publicado: (2007)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri, Hideaki, et al.
Publicado: (2018)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1j4ojg2sqaf475279mqkjtigch